Public trial registry of the CCC-Munich

Trial IMMUNIB

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
IMMUNIB
World
Full title
:

IMMUNIB – Eine offene, einarmige Phase-II-Studie zur Immuntherapie mit Nivolumab in Kombination mit Lenvatinib bei hepatozellulärem Karzinom (HCC) im fortgeschrittenen Stadium

World
Description
:

This is an exploratory, open-label, single arm, multicenter phase II trial for the evaluation of efficacy and feasibility (as determined by safety and tolerability) of immunotherapy with nivolumab in combination with lenvatinib for patients with multinodular, advanced stage hepatocellular carcinoma in first line therapy

World
EudraCT number
:
World
NCT number
:
World
Responsible organization
:
Medizinische Klinik II, Telefon: 089440072791
Indications
Classification Code Description
ICD-10-GM C22.0 Leberzellkarzinom
- Livertumor
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Open
World
Phase
:
II
Status
World
Status
:
Recruitment finished
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
2022-05-31 / Unknown
Therapy
World
Therapy line
:
1
Participants
Function Prename Surname Organization
World Principal Investigator Enrico Toni Keine Organisationseinheit angegeben Magnifier
World Responsible contact ALEXANDER PHILIPP Keine Organisationseinheit angegeben Magnifier